Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Anorectal combo non-monograph

This article was originally published in The Tan Sheet

Executive Summary

The combination of hydrocortisone and pramoxine HCl is not safe and effective for OTC anorectal drugs, FDA says in a final rule slated to be published in the Aug. 25 Federal Register. Data provided in support of the ingredients "did not involve a patient population where the product is intended for OTC use, nor were they for the proposed OTC anorectal indication," agency says. There currently are no OTC products that contain the combination, FDA notes. Ferndale Labs requested monograph status for the ingredient combination following release of the 1988 final rule on anorectal products (1"The Tan Sheet" Feb. 14, 1994, p. 8)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095832

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel